Shuchen Hu
Biographic Data
| ID | 6264592 |
|---|---|
| NAME | Shuchen Hu |
| GIVEN NAMES | Shuchen |
| FAMILY NAME | Hu |
| SIGNATURE | HU S |
| AFFILIATIONS | Xi'an Jiaotong University |
| ORCID | 0000-0003-4849-6829 |
| VERIFIED | Yes |
| TOTAL WORKS | 5 |
| TOTAL CITATIONS | 0 |
| AUTHOR COUNT | 5 |
| EDITOR COUNT | 0 |
| FIRST PUBLICATION YEAR | 2023 |
| LATEST PUBLICATION YEAR | 2025 |
| H-INDEX | 0 |
Digital health
Digital Health Technologies (DHTs) have become a cornerstone of modern healthcare, significantly improving quality and safety across clinical practice, public health, and medical research. Originating in the mid-to-late 20th century, DHTs have facilitated substantial progress in personalized medicine, predictive analytics, and remote patient monitoring through the implementation of artificial intelligence (AI), wearable devices, and telemedicine …
The association between drug shortages and prices across 74 countries
BACKGROUND: Drug shortages are a global concern that poses risks to clinical care and health systems. Lower prices and market pressures are often cited as drivers of drug shortages; thus, a commonly proposed policy lever is to increase drug prices. However, global evidence to evaluate the association between shortages and prices is lacking. This research aims to fill the gap by examining the global markets of drug shortages. METHOD: We included 2…
Confirmatory Trials for Drugs Granted Conditional Approval by the Chinese National Medical Products Administration
This cross-sectional study analyzes differences in pivotal and confirmatory trial characteristics for drugs granted conditional approval in China
Development of the modified Highly Processed Food Withdrawal Scale (mProWS)
The impact of drug shortages on drug prices
Introduction: Drug shortages pose a serious global public health challenge, affecting China and other countries. Evidence from USA shows that short-supplied drugs demonstrated a very high price growth during and after a shortage. However, the effect of shortages on drug prices in China remains unknown. This paper aims to understand the impact of drug shortages on prices and explore implications for shortage prevention policy. Methods: We collecte…
No prominent works on this page.
The impact of drug shortages on drug prices
Introduction: Drug shortages pose a serious global public health challenge, affecting China and other countries. Evidence from USA shows that short-supplied drugs demonstrated a very high price growth during and after a shortage. However, the effect of shortages on drug prices in China remains unknown. This paper aims to understand the impact of drug shortages on prices and explore implications for shortage prevention policy. Methods: We collecte…
Confirmatory Trials for Drugs Granted Conditional Approval by the Chinese National Medical Products Administration
This cross-sectional study analyzes differences in pivotal and confirmatory trial characteristics for drugs granted conditional approval in China
Development of the modified Highly Processed Food Withdrawal Scale (mProWS)
Digital health
Digital Health Technologies (DHTs) have become a cornerstone of modern healthcare, significantly improving quality and safety across clinical practice, public health, and medical research. Originating in the mid-to-late 20th century, DHTs have facilitated substantial progress in personalized medicine, predictive analytics, and remote patient monitoring through the implementation of artificial intelligence (AI), wearable devices, and telemedicine …
The association between drug shortages and prices across 74 countries
BACKGROUND: Drug shortages are a global concern that poses risks to clinical care and health systems. Lower prices and market pressures are often cited as drivers of drug shortages; thus, a commonly proposed policy lever is to increase drug prices. However, global evidence to evaluate the association between shortages and prices is lacking. This research aims to fill the gap by examining the global markets of drug shortages. METHOD: We included 2…
Medicine (3 works) · Pharmaceutical Economics and Policy (3 works) · Business (2 works) · China (2 works) · Economic shortage (2 works) · Health Systems, Economic Evaluations, Quality of Life (2 works) · Pharmaceutical Quality and Counterfeiting (2 works) · Administration (probate law (1 work) · Artificial Intelligence in Healthcare and Education (1 work) · Biomedical Ethics and Regulation (1 work)